Tonino, Tweardy, Wegerich, Brouwer Zwaginga, Schipperus
We monitored 5 patients who regularly received transfusions during one transfusion cycle with the accelerateIQ biosensor platform, the Withings Steel HR, and web-based cognitive and quality of life testing. The deployed devices rendered qualitative and usable data. Heart rate decreased and cognition improved significantly following RBC transfusions. Activity and quality of life measures did not show transfusion-induced changes.
Digital Biomarkers (2022)
Digit Biomark 2022;6:117-126